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1t a ~  controls (4.0 ~: 1.5 yoars), PRA was detenn~a~ against an 
All blood Ixoducts were iwadiated and leu~f i i temd.  After allograft im~ 
plantation, PRA increased from 3.2.2.7% (before Surgery) to 63.3 :E 12% 
(25 ~ 2 days after slffge~y) and 99.7 • 0.3% (3A ~: 0.3 months a~ter smgepj), 
Use of ddhioglmit~ to mmo~ IgM resulted in a modest decrease in PIRA at 
one m0nth (to 33.2 • 13%) but no change In PRA at 3 months (93,0 ± 3.4%), 
~ n g  inilJaJ PRA is pa~afly tgM but becomss almost exdusively IgG ~ 
3 monlJls. By 3 ~ ,  PRA was fotmd to be spedfic against HLA Class I 
and of h l~ titm. ConT~ pa~enls howed no increase in PRA ovm time: 1.6 =E 
1% (before surge~), 3.2:1:1% (28 + 5 days afl~" sm~je~), and 1.7 :E 1.2% 
(2,7 + 0.3 months after su~oery). We eondude that cm~sen/ed  valved 
allogra/Is in children [r~l_ t',:'+_ a mmked antibody response ~ ino"eaSes to
b'oad panel reac~ within 3 m0nths m'tm surgew. Tlds HLA sensif~a~on 
Im ~ not only for causing delsta~o,s effects on agogr~ funct~n b,t 
~;o tot limiting the future Ol~OrtUn~ of heart Iransldantalio~ in 10~ients who 
recak.e a~m~s. 
Predictors o f  Hypertension In Long Term 
- Sundvor3 of ~ Coarclallon of lhe Aorta 
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To evaluate fa~om ~ with the development of syste~¢ hypenen- 
don (HBP) in pts following coarctaSon of the aorta (COA), we eva.a~ed 68 
0perative stm,,k, om of COA repair. From 195£ to 1972, 277 pts suwived COA 
repair at the univ. of MN. Sixty.six pts were lost to fogow-up and ~rz77 
operaSve ~ were randomly selected to ~ in this study. Blood 
pressure was remm+x~ely d e ~  from ~ne firm l )OSt -op~ visit 
(v+) [n~dlan 0.25 yrs post repalr) and the mast reo~rd~ visit (V'Z) (mec~ 
5.9 yrs post repair). Olood presswe w'~s ~ ~ us~ t~e 
random zero meU~ in s6A;e pt~ (vs) [me~ 24.9 ym post.op), i:'ts were 
divided in two Oroups besed on the presence of HOP at thelr most recent vlsit 
(HBP (31) and Nor~HBP Gp). HBP was defined as systolic or d~astol'= blood 
pressure > 95th %~le for age and sex or being treated Wlth HBP medicatio,s. 
N Sex ~ ,SBP Years C~ 
. . . . . . . .  (M/~ . . . . . . .  my1 ~,o...p ao. a,.wo 0rod 
HBP 3~ 25/tl 9.1d:1E6 141~19 P9+16 35'~10 -0.84"1t 
NI.IBP 36 26/6 7.24-5.9 113d~16 2EL4"9 41&16 -8.34-9,6 
P 68 I~ 0.0001 <0.0001 0.87 0.1 0.01 
~Ut~o~h age at opera,on and re~ng annneg grae%~t were 
~mt between m two Oroups. when a, of the above favors were e~e~d 
tn a multiple Iogisl~ mgmssk~ analysis, SPB et V1 was lhe only s i ~  
ix~dictm of HBP at V3 (p = 0.004). Notably, 18 out of 32 I l y~ ive  pad~rds 
bed been hy~ive  at VI, In summary, HBP is a common problem 
fi)llowi~g mpa;." of GOA and occtmed in 32/68 (47%) pls. Pemistence of HBP 
at ~e first po~st-op visit is Ihe most impodant ~ of hypeh'ension at la~ 
f01k~H~p. 
PERIPHERAL VASCULAR 
DISEASE/THROMBOSIS/EMBOLISM- CLINICAL 
~ Revascularizatlon Achieved by Therapeutic 
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Th~ em~acy ~"merapeut~" a~0enesis to ind, o~ m a ~  re~a~u- 
~za ,  o, a,d to ~mve hewo~ I ~  has ~em ~ 
In ~rhmnt ischemk: models. However Its e~cacy to sig, iflca, dy imp,~ 
~ pedusim at a ~ level has bern q~'~aL  Acco~ngly we 5~st~ 
0atod Um elect of angtogenic d~apy with vas~dar e~othe, al growth favor 
(VEGF) on muscle pedusian in a rabbit ~ of chmnlc hlnd~nb isd~m~ 
In addiUe~ we evaluated the relask)ns~ behveen rmJ~de perfus~ and the 
oU~r parametem m revamdadzatk)n (eoUateral fo.naUm, f01ood pmss,m 
and ~ now). Musde ped.slon was ~sess~d by ~ of cotomd 
ndcrospheros (15 p.m diametor) b"~4~ped in hin~rind~ mt~des f0tiowin0 an in- 
Vacaldiac admlnlsb-alion. Sixteen New Zealand ralddts Lmdem'ent mr, ectlon 
of one femoral mte~y. Ten days lat~" (day 0), IxaseS"ne meassmmmnts of ~alf 
U o o d ~ x ; ~  scm ~c~ter~ ~rma.o.: ~mvasc,W 
Dopraer-wire ana~ of ,iac u~m no~, and ~ an,~s~ of 
tousle pedusion were ~ .  Each animal hen received In~a-E~ VEGF 
(500/zg, n = 8) or vehide (n = 8), followed by the same dose i.v. ~t days 2 and 
4. At ~y  30 all ~ were ~.~d a,d the ~ sac~c~ 
VEGP Group 60.9 =1:5,5 91 +8 4" 6.8* 
Coldrol gl~op 64,1 4-4,4 73J~ 4" 2,5 
% = % of nom~ 5rd~;,,p < 0.81 vs ¢~x~l day 30 and vs all dsy 0. 
I.inear egmssi~ Collateral Bood pmsswe l~ac l~o~d 
analy~; R va l~ fonnatie~ index flow 
T~su~ t ~  0+88* 0.76* 0.81" 
*AIr p ~'~_5_ '~_ for ~kmaJr r~ l~ s~aly.~ < 0.(X)0S. 
"these ins,its show: 1) VEGF~no~ed ang~e.e~ imp,'ov~ 5ss,e pe~- 
fusion; 2) there is a dear ~ Jo .sh ip  between Ihe degree of mvasculadza~n 
achieved and the ~ of ~; .e  pedusk~. "this st.dy demonstr~es 
the Idlysiok)glcal ~¢a~e of in~roveme~ obsmved with g~mth factor. 
Evidence for  the InVacardiovascular 
~ Slate Induced by Aldal  Fibril lation 
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To evaluato whether the in~vasct~ hypemlov.Unn state would be induced by 
atriaJ llbn~5on (Aq rot Itse~ rather than e~anlc l~eart msea.~e, p~sma ~/e~s 
ot ~ .  thromt~anSU.o.ddn 3 ~m~,L~ _ .  ('rAT) and a~ha~-.p~..~,~ 
inhiidtoPplasmin complexes (PIC) were measmed in consecusve 17 paSents 
Lots) with paroxysmal ~ ~ (PA~). Of the ~7 pts ( ~  = 
t 1/6, 62 ','- 14 y.o.), foLa' h~l ischemtc Iteatt ¢ssease, tlzree had vaMdar Itea~t 
disease, two had ped- or myocant~ one had s~k r, inus ~ and 
IN) ~ 7 I~  had no oq]aniC heart dise~tses, PN was c(mverl~d to 
slnus dW'd~ |SR) by eleeblcal car(5overs~n (n = 5) or spontaneously (n = 
12). The pla.~na D.dimer, TAT and PIC values we, re m~m,red by enzyme 
i n k y  al the end of PAl (End o~ PN) and 24 hours a~r  convemion 
to SR (24 H Ntm). The m~ duration of PN was 4B~ (3-330 hm)+ The 
~u~s were as mow, baow; 
D4f~mer (ng/ml) ..... TAT (ng/ml) PIC (pO/n~ 
End (~ PAf IG0:1:38 8.2+2.,5 0.66~ 0.10 
24 H/~m' 1~-  28 * 3.1 ~: 0.5" 0.b';7 ~ 0.08 
m~an ~= SE, °p < 0.05,vs End of PN 
The D-elmer and TAT values 24 I~  after ¢onvemion from N to SR were 
slgni~anlly lower dWn g~se al the end ol N. ~ ,  the char<jes in 
p~;ma levels of D-Q,m~, TAT. and PIC did not shaw significant dilemrces 
between pts w;th and without o~uan~ heart _d~_  ___ On the oth~ hand, 
none of D-dimm., TAT or PlC vakBs at Iha end of N s~n~andy conelated 
with the ~ of N. These mst~ i rdc~ l~a~ at~l lb~Jon  tor ~lseg 
would coNdb~ to increase ~e ~ ~1o~1 and that the 
"_ant~_ _~on theraW for Paf m~ht be mcon,nended i~ the du~o~ of N 
would be over 3 hour¢ 
~ Soluble Adhesion Molecule P .~Sele~,  Yon 
Wil lebmd Factor md ~ in A~ 
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Grego~ YM. Lip, J01~ Zadl~ Andrew Bann, Safaf Famoqt, Clan -_~,-~-m~_ ~ , 
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a ~ :  Untver~ H~sp~ # ,S~th Max~,  F-~and 
To ~ t e  end~he~ funcUon and ~ 3  ~xmna, Ues ~ 
stroke, we meas~ed levels of m soluble adhe~on molecule P ~  
(B .L~ PJm sym~s; assoda~d v~th e~e~ a~ ~ ac,v~n~r~ 
tion), yon Wigelxand factor (vWf; DAKO; a mad~ of e~lotheSal dysfunction), 
flbdnoOm (CLAUSS) an~ omer haemod~ok~k;~ b d~es (pLasn,a v~os~.  
Amestmke 
fd~nogen (g/I) $.6 =k 0,9 3.04:0.6 t-line p = 0.803 
Plasma ~sctl~y 1.73=1:0+15 1.66=!:0+09 t-te~ p., 0.04 
WCC.(x lo~n.) e~.  2.~ s .~.  1.7a t-t~.p < 0.~1 
BIo~ Pms~ 158.1/IB9.8 130.3/80.6 t-test, bo~h p< 0.00"; 
p,.se~ec~. (nO/n/) 41S (2S~-~8) 212 (lS0-,-'m) p-  o.0o~ 
~( IU~ ~ |56 (126-176),,,, !06 [6~121) p < 0.001 
nman + r,.d. 
